1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RPGRIP1L CTRPv2 pan-cancer AAC -0.096 0.01
mRNA NDUFS2 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA PTPRG CTRPv2 pan-cancer AAC -0.091 0.01
mRNA NTMT1 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA CLRN3 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA LRCH3 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA DPAGT1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA RPP30 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA HAGHL CTRPv2 pan-cancer AAC 0.094 0.01
mRNA VEGFC CTRPv2 pan-cancer AAC -0.097 0.01
Download CSV